Tumor cell membrane‑coated MOF‑199 nanoparticles co‑loaded with auranofin and celecoxib enhance single‑dose radiotherapy and anti‑PD‑L1 therapy in cervical cancer
Authors:
Open Access
- 25 September 2026
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1) , 916
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province (2022JJ30868)
- Natural Science Foundation of Hunan Province (2026JJ81334)
- Key Research and Development Program of Hunan Province of China (2026AQ2002)
This publication has 48 references indexed in Scilit:
- Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancerCancer, 2025
- Self‐Reinforced Bimetallic Mito‐Jammer for Ca 2+ Overload‐Mediated Cascade Mitochondrial Damage for Cancer Cuproptosis SensitizationAdvanced Science, 2024
- A tumor microenvironment-activated metal-organic framework–based nanoplatform for amplified oxidative stress–induced enhanced chemotherapyJournal of Biological Chemistry, 2022
- The thioredoxin system: Balancing redox responses in immune cells and tumorsEuropean Journal of Immunology, 2022
- Cu-MOF chemodynamic nanoplatform via modulating glutathione and H2O2 in tumor microenvironment for amplified cancer therapyJournal of Colloid and Interface Science, 2021
- Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insightsDrug Discovery Today, 2021
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Immunity, 2018
- Immunogenic effects of chemotherapy-induced tumor cell deathGenes & Diseases, 2018
- The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritisInternational Immunopharmacology, 2014
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997